White Lotus Sparks 40% Rise in Lorazepam Searches
Internet searches for anti-anxiety drug lorazepam jumped 40% following its depiction in The White Lotus, raising concerns about media influence on prescription drug use.
Internet searches for anti-anxiety drug lorazepam jumped 40% following its depiction in The White Lotus, raising concerns about media influence on prescription drug use.
Heavyweight boxer Joseph Parker failed a VADA drugs test on the day of his October fight against Fabio Wardley, potentially ending his career. Full details revealed.
Isabelle Dale, 23, sobbed in court after being convicted for affairs with two inmates and smuggling synthetic cannabis into HMP Coldingley. She faces a substantial jail sentence.
Next week's explosive EastEnders sees Vicki Fowler's trauma spiral into violence while Zack Hudson intervenes, sparking romantic complications. Plus: Ravi faces consequences and adoption drama continues.
UK authorities warn of sophisticated fake weight-loss drugs manufactured by organised crime. Learn how to spot counterfeit products and protect your health.
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
Exclusive investigation reveals rising substance abuse at British weddings, from cocaine in bathrooms to MDMA on dance floors. Discover the highs, lows and sobering reality.
World Anti-Doping Agency president issues stark warning against proposed Enhanced Games, calling them 'dangerous' and demanding immediate action to prevent their launch.
Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.